OTC label warning consolidation raised at OTC "feedback" meeting.
This article was originally published in The Tan Sheet
OTC LABEL WARNING CONSOLIDATION FLOATED AS POSSIBLE SOLUTION to the space problem expected by industry from FDA's proposed requirement that labels be printed in a minimum type size of 6 points. At a May 8 OTC "feedback" meeting, Nonprescription Drug Manufacturers Association Senior VP and Scientific & Regulatory Affairs Director William Soller, PhD, asked FDA whether overcrowding might be addressed by "further" consolidating warnings by, for example, merging two warning subheadings on one line.
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC